Nektar Therapeutics | Umsatzkosten





Umsatzkosten Veränderung Datum
Agios Pharmaceuticals USD 1.68M 22K 2025-09
ALKERMES USD 51.59M 2.13M 2025-09
Amgen USD 1.79B 128M 2025-12
Baxter International USD 1.88B 66M 2025-09
BioCryst Pharmaceuticals USD 12.27M 9.04M 2024-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cara Therapeutics USD 0 0 2025-03
Cipla INR 29.1B 1.16B 2025-12
Dr.Reddys Laboratories INR 36.16B 3.75B 2025-12
Eisai JPY 51.08B 5.56B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Exelixis USD 26.48M 7.91M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.32B 22.75M 2025-09
Halozyme Therapeutics USD 73M 8.88M 2025-09
Incyte USD 121.18M 22.18M 2025-12
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
MacroGenics USD 44.3M 5.4M 2025-09
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 264M 252.7M 2025-09
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Xencor USD 61.66M 50.95M 2025-06


Nektar Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.